ArticleNeoplasia (New York, N.Y.)2015

Erlotinib-cisplatin combination inhibits growth and angiogenesis through c-MYC and HIF-1α in EGFR-mutated lung cancer in vitro and in vivo.

Jasmine G Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.